Click Here for 5% Off Your First Aladdin Purchase!

Poly(ethylene glycol) - Ultrapure BioReagent, 3,000, high purity , CAS No.25322-68-3

  • BioReagent
  • Ultra pure
  • UltraBio™
  • 3000
Item Number
P432423
Grouped product items
SKUSizeAvailabilityPrice Qty
P432423-250g
250g
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$132.90

Basic Description

SynonymsPEG
Specifications & PurityUltrapure BioReagent, 3,000
Storage TempStore at 2-8°C
Shipped InWet ice
GradeBioReagent, Ultra pure, UltraBio™
Product Description

Poly(ethylene glycol) (PEG) is a non-ionic hydrophilic polymer and is available in different molecular weights. It helps in the purification and crystal growth of proteins and nucleic acids. PEG and dextran together result in aqueous polymer two phase system, which is required for the purification of biological materials. PEG also interacts with cell membrane, thereby allowing cell fusion.


Application

Poly(ethylene glycol) (PEG) has been used to study PEG-β lactoglobulin interaction. It has also been used to study the interaction of serum albumins with PEG.

Names and Identifiers

Canonical SMILES C(CO)O
WGK Germany 1

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

Chemical and Physical Properties

SolubilityH2O: 50mg/mL at20°C, clear, colorless
Refractive Index1.460
Flash Point(°C)138.6 °C
Boil Point(°C)> 200 °C
Melt Point(°C)42-50℃

Safety and Hazards(GHS)

WGK Germany 1
Merck Index 7568

Related Documents

References

1. D D Smyth,P I Polimeni.  (1990-02-01)  Drag-reducing polymers: a novel class of diuretic and natriuretic compounds..  Cardiovascular drugs and therapy,  ((1)): (297-300).  [PMID:2285623]
2. P I Polimeni,B T Ottenbreit.  (1989-09-01)  Hemodynamic effects of a poly(ethylene oxide) drag-reducing polymer, Polyox WSR N-60K, in the open-chest rat..  Journal of cardiovascular pharmacology,  14  ((3)): (374-380).  [PMID:2476615]
3. Mark A Rice,Kendall R Waters,Kristi S Anseth.  (2008-09-17)  Ultrasound monitoring of cartilaginous matrix evolution in degradable PEG hydrogels..  Acta biomaterialia,  ((1)): (152-161).  [PMID:18793879]
4. M Patel Geeta,M Patel Madhabhai.  (2009-05-20)  Design and in vitro evaluation of a novel vaginal drug delivery system based on gelucire..  Current drug delivery,  ((2)): (159-165).  [PMID:19450222]
5. Idalis Villanueva,Courtney A Weigel,Stephanie J Bryant.  (2009-06-11)  Cell-matrix interactions and dynamic mechanical loading influence chondrocyte gene expression and bioactivity in PEG-RGD hydrogels..  Acta biomaterialia,  ((8)): (2832-2846).  [PMID:19508905]
6. Thomas McNerney,Anne Thomas,Anna Senczuk,Krista Petty,Xiaoyang Zhao,Rob Piper,Juliane Carvalho,Matthew Hammond,Satin Sawant,Jeanine Bussiere.  (2015-02-24)  PDADMAC flocculation of Chinese hamster ovary cells: enabling a centrifuge-less harvest process for monoclonal antibodies..  mAbs,  ((2)): (413-428).  [PMID:25706650]
7. L Bekale,D Agudelo,H A Tajmir-Riahi.  (2015-04-14)  The role of polymer size and hydrophobic end-group in PEG-protein interaction..  Colloids and surfaces. B, Biointerfaces,  130  (141-148).  [PMID:25865167]
8. J Huang, Z Chen, C Wen, T Ling, Z Chen.  (2022)  Thermally assisted 3D printing of bio-polymer with high solute loading with improved mechanical properties.  Additive Manufacturing,    (59A): (103088).  [PMID:]

Solution Calculators